CLINICAL_TRIALS
withdrawal
· 2010-02-02
Clinical Trial Update: Pioglitazone in Impaired Glucose Tolerance [Phase 4]
Summary
A Phase 4 clinical trial examining pioglitazone for impaired glucose tolerance was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Leipzig | Conditions: Glucose Metabolism Disorders | Phase 4 | Status: WITHDRAWN